Xilin Wu
6PUBLICATIONS
33CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 19, 2025
A rationally designed cocktail of nanobodies elicited by heterologous vaccination confers protection against SFTSV in preclinical models.Xilin Wu, Linjing Zhu, Shengjian Liang
|Sep 19, 2025
Pharmacokinetic-pharmacodynamic modeling of a highly potent and broadly neutralizing anti-CD4 trimeric nanobody to inhibit HIV-1 infection.Xiaoqing Fan, Kangna Cao, Xilin Wu
|Aug 13, 2024
Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alteration.Linjing Zhu, Bilian Huang, Xiangyao Wang
|Feb 17, 2024
Inhibition of SFTSV replication in humanized mice by a subcutaneously administered anti-PD1 nanobody.Mengmeng Ji, Jiaqian Hu, Doudou Zhang
|Jun 24, 2021
AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia.Waqas Nawaz, Bilian Huang, Shijie Xu
|May 11, 2021
Infection of humanized mice with a novel phlebovirus presented pathogenic features of severe fever with thrombocytopenia syndrome.Shijie Xu, Na Jiang, Waqas Nawaz
Pageof 1
